Market Overview:
The global bioabsorbable vascular stents market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in bioabsorbable vascular stents, and rising demand for minimally invasive procedures. However, the high cost of treatment and limited reimbursement policies are restraining the growth of this market. Based on type, the global bioabsorbable vascular stents market is segmented into polymer-based bioabsorbable stents and metal-based bioabsorbable stents.
Product Definition:
A bioabsorbable vascular stent is a type of stent that is made from a material that will dissolve over time after it has been placed in the body. This type of stent is often used to keep blood vessels open in patients who have had a heart attack or who are at risk for one.
Polymer-Based Bioabsorbable Stents:
Polymer-based bioabsorbable stents are made of polymers and have the ability to degrade or biodegrade in a predictable manner. They are used as scaffolds that support cells and promote healing by restricting bleeding, maintaining pressure, and preventing re-accumulation of blood clotting factors. Polymer-based bioabsorbable stents can be customized for use in various applications such as orthopedic, neurovascular & urological procedures.
Metal-Based Bioabsorbable Stents:
Metal-based bioabsorbable stents are used in the treatment of thoracic and abdominal aortic aneurysms. The product is made up of biocompatible metals such as stainless steel, titanium, nickel alloys, chromium alloys and copper. These metal-based stents can be taken out after 6 to 12 months with minimal risk for the patient.
Application Insights:
The coronary artery segment dominated the global market in terms of revenue share in 2017. This is due to a high incidence of coronary artery diseases, which are the most common type of all heart diseases. According to data published by WHO, it has been estimated that globally around 370,000 deaths occur due to these diseases every year.
Moreover, increasing awareness about cardiovascular disease and its management is expected to boost product demand over the forecast period. In addition, bioabsorbable stents have been found effective in reducing long-term side effects as well as complications when compared with conventional metal or polymeric-based stents that are used for treating this condition. These factors are anticipated to increase market penetration over the forecast period (see Table 1).
Table 1: Comparison between conventional metal or polymer-based vascular implants.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable healthcare policies, increasing prevalence of cardiovascular diseases and presence of major market players such as Boston Scientific Corporation; Medtronic; Zimmer Biomet; and Abbott. Moreover, growing number of FDA approvals for new products is also expected to drive the regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising geriatric population with cardiac problems coupled with improving economic conditions in emerging countries such as China and India. In addition, rapidly developing healthcare infrastructure along with increasing medical tourism are some other factors driving this regional demand.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Rising geriatric population
- Growing demand for minimally invasive procedures
- Technological advancements in bioabsorbable vascular stents
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioabsorbable Vascular Stents Market Research Report
By Type
Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents
By Application
Coronary Artery Stent, Peripheral Artery Stent
By Companies
Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International, BIOTRONIK SE & Co., Meril Life Sciences, Kyoto Medical Planning, Medtronic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Bioabsorbable Vascular Stents Market Report Segments:
The global Bioabsorbable Vascular Stents market is segmented on the basis of:
Types
Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Coronary Artery Stent, Peripheral Artery Stent
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Abbott Laboratories
- Boston Scientific Corporation
- Biosensors International
- BIOTRONIK SE & Co.
- Meril Life Sciences
- Kyoto Medical Planning
- Medtronic
Highlights of The Bioabsorbable Vascular Stents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polymer-Based Bioabsorbable Stents
- Metal-Based Bioabsorbable Stents
- By Application:
- Coronary Artery Stent
- Peripheral Artery Stent
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioabsorbable Vascular Stents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioabsorbable vascular stents are a type of medical device that is inserted into an artery to prevent it from closing off. They are made out of a material that can be absorbed by the body over time, and they can be removed if the person no longer needs them.
Some of the major players in the bioabsorbable vascular stents market are Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International, BIOTRONIK SE & Co., Meril Life Sciences, Kyoto Medical Planning, Medtronic.
The bioabsorbable vascular stents market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bioabsorbable Vascular Stents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bioabsorbable Vascular Stents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bioabsorbable Vascular Stents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bioabsorbable Vascular Stents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bioabsorbable Vascular Stents Market Size & Forecast, 2020-2028
4.5.1 Bioabsorbable Vascular Stents Market Size and Y-o-Y Growth
4.5.2 Bioabsorbable Vascular Stents Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Polymer-Based Bioabsorbable Stents
5.2.2 Metal-Based Bioabsorbable Stents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Coronary Artery Stent
6.2.2 Peripheral Artery Stent
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bioabsorbable Vascular Stents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bioabsorbable Vascular Stents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Polymer-Based Bioabsorbable Stents
9.6.2 Metal-Based Bioabsorbable Stents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Coronary Artery Stent
9.10.2 Peripheral Artery Stent
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Polymer-Based Bioabsorbable Stents
10.6.2 Metal-Based Bioabsorbable Stents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Coronary Artery Stent
10.10.2 Peripheral Artery Stent
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Polymer-Based Bioabsorbable Stents
11.6.2 Metal-Based Bioabsorbable Stents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Coronary Artery Stent
11.10.2 Peripheral Artery Stent
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Polymer-Based Bioabsorbable Stents
12.6.2 Metal-Based Bioabsorbable Stents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Coronary Artery Stent
12.10.2 Peripheral Artery Stent
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Polymer-Based Bioabsorbable Stents
13.6.2 Metal-Based Bioabsorbable Stents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Coronary Artery Stent
13.10.2 Peripheral Artery Stent
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bioabsorbable Vascular Stents Market: Competitive Dashboard
14.2 Global Bioabsorbable Vascular Stents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Abbott Laboratories
14.3.3 Boston Scientific Corporation
14.3.4 Biosensors International
14.3.5 BIOTRONIK SE & Co.
14.3.6 Meril Life Sciences
14.3.7 Kyoto Medical Planning
14.3.8 Medtronic
